Druggio Logo

Druggio

Mitsubishi Tanabe Pharma

Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company established in 1678 and has a strong focus on the research and development of innovative drugs for the treatment of neurological and autoimmune diseases. The company is known for its expertise in areas such as multiple sclerosis, amyotrophic lateral sclerosis (ALS), and rheumatoid arthritis. Mitsubishi Tanabe Pharma is committed to advancing scientific knowledge and developing effective therapeutic options for patients worldwide.

Mitsubishi Tanabe Pharma's Drugs

Vafseo

Approval date

2020/6/29

Treats

Canaglu

Approval date

2014/7/4

Tenelia

Approval date

2012/6/29

Ceredist

Approval date

2000/7/3